An electrophilic warhead library for mapping the reactivity and accessibility of tractable cysteines in protein kinases
出版年份 2020 全文链接
标题
An electrophilic warhead library for mapping the reactivity and accessibility of tractable cysteines in protein kinases
作者
关键词
Warhead selection, Kinase cysteome profiling, Targeted covalent inhibitors, Small-molecule kinase inhibitors, JAK3, MELK
出版物
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 207, Issue -, Pages 112836
出版商
Elsevier BV
发表日期
2020-09-12
DOI
10.1016/j.ejmech.2020.112836
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparative reactivity analysis of small-molecule thiol surrogates
- (2020) László Petri et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Mass spectrometry–based selectivity profiling identifies a highly selective inhibitor of the kinase MELK that delays mitotic entry in cancer cells
- (2020) Ian M. McDonald et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Covalent fragment libraries in drug discovery
- (2020) Aaron Keeley et al. DRUG DISCOVERY TODAY
- MELK inhibition targets cancer stem cells through downregulation of SOX2 expression in head and neck cancer cells
- (2019) Lili Ren et al. ONCOLOGY REPORTS
- Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma
- (2019) Alexandre Chlenski et al. MOLECULAR CANCER THERAPEUTICS
- Assessing Lysine and Cysteine Reactivities for Designing Targeted Covalent Kinase Inhibitors
- (2019) Ruibin Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- MEK/MELK inhibition and blood–brain barrier deficiencies in atypical teratoid/rhabdoid tumors
- (2019) Michaël H Meel et al. NEURO-ONCOLOGY
- Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma
- (2019) Antonio Cigliano et al. Medicina-Lithuania
- Progress with covalent small-molecule kinase inhibitors
- (2018) Zheng Zhao et al. DRUG DISCOVERY TODAY
- Design, synthesis, and SAR study of highly potent, selective, irreversible covalent JAK3 inhibitors
- (2018) Linhong He et al. MOLECULAR DIVERSITY
- Advanced Activity-Based Protein Profiling Application Strategies for Drug Development
- (2018) Shan Wang et al. Frontiers in Pharmacology
- How Reactive are Druggable Cysteines in Protein Kinases?
- (2018) Ernest Awoonor-Williams et al. Journal of Chemical Information and Modeling
- A road map for prioritizing warheads for cysteine targeting covalent inhibitors
- (2018) Péter Ábrányi-Balogh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology
- (2018) Matthias Gehringer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Expanding the Armory: Predicting and Tuning Covalent Warhead Reactivity
- (2017) Richard Lonsdale et al. Journal of Chemical Information and Modeling
- Statistical Analysis and Prediction of Covalent Ligand Targeted Cysteine Residues
- (2017) Weilin Zhang et al. Journal of Chemical Information and Modeling
- Determining Cysteines Available for Covalent Inhibition Across the Human Kinome
- (2017) Zheng Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans
- (2017) Atli Thorarensen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition
- (2016) Jean-Baptiste Telliez et al. ACS Chemical Biology
- Targeted Covalent Inhibitors for Drug Design
- (2016) Thomas A. Baillie ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Osimertinib (AZD9291)—a science-driven, collaborative approach to rapid drug design and development
- (2016) A. Yver ANNALS OF ONCOLOGY
- Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
- (2016) Jingjing Wu et al. Journal of Hematology & Oncology
- Toward the Validation of Maternal Embryonic Leucine Zipper Kinase: Discovery, Optimization of Highly Potent and Selective Inhibitors, and Preliminary Biology Insight
- (2016) B. Barry Touré et al. JOURNAL OF MEDICINAL CHEMISTRY
- Kinetics and Thermodynamics of Reversible Thiol Additions to Mono- and Diactivated Michael Acceptors: Implications for the Design of Drugs That Bind Covalently to Cysteines
- (2016) Elizabeth H. Krenske et al. JOURNAL OF ORGANIC CHEMISTRY
- Twenty years on: the impact of fragments on drug discovery
- (2016) Daniel A. Erlanson et al. NATURE REVIEWS DRUG DISCOVERY
- A comprehensive map of molecular drug targets
- (2016) Rita Santos et al. NATURE REVIEWS DRUG DISCOVERY
- Covalent protein modification: the current landscape of residue-specific electrophiles
- (2015) D Alexander Shannon et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies
- (2015) Renato A. Bauer DRUG DISCOVERY TODAY
- Systematic Study of the Glutathione (GSH) Reactivity of N-Arylacrylamides: 1. Effects of Aryl Substitution
- (2015) Victor J. Cee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of Selective Covalent Janus Kinase 3 Inhibitors
- (2015) Li Tan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tuning the Electronic Properties of 2-Cyano-3-phenylacrylamide Derivatives
- (2015) Ramachandran Gunasekar et al. JOURNAL OF ORGANIC CHEMISTRY
- Kinase inhibitors and monoclonal antibodies in oncology: clinical implications
- (2015) Helen Gharwan et al. Nature Reviews Clinical Oncology
- Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active Site Thiol
- (2015) Eric R. Goedken et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring
- (2014) Kai Zhu et al. Journal of Chemical Information and Modeling
- Chemical and Computational Methods for the Characterization of Covalent Reactive Groups for the Prospective Design of Irreversible Inhibitors
- (2014) Mark E. Flanagan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Covalent docking of large libraries for the discovery of chemical probes
- (2014) Nir London et al. Nature Chemical Biology
- Developing Irreversible Inhibitors of the Protein Kinase Cysteinome
- (2013) Qingsong Liu et al. CHEMISTRY & BIOLOGY
- Dacomitinib, a new therapy for the treatment of non-small cell lung cancer
- (2013) Christina Brzezniak et al. EXPERT OPINION ON PHARMACOTHERAPY
- Kinome Render: a stand-alone and web-accessible tool to annotate the human protein kinome tree
- (2013) Matthieu Chartier et al. PeerJ
- Thermodynamics of Fragment Binding
- (2012) György G. Ferenczy et al. Journal of Chemical Information and Modeling
- Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial
- (2012) Vincent A Miller et al. LANCET ONCOLOGY
- Electrophilic natural products and their biological targets
- (2012) Malte Gersch et al. NATURAL PRODUCT REPORTS
- Cysteine Mapping in Conformationally Distinct Kinase Nucleotide Binding Sites: Application to the Design of Selective Covalent Inhibitors
- (2011) Emeline Leproult et al. JOURNAL OF MEDICINAL CHEMISTRY
- The electrostatic potential: an overview
- (2011) Jane S. Murray et al. Wiley Interdisciplinary Reviews-Computational Molecular Science
- Local Electrophilicity Predicts the Toxicity-Relevant Reactivity of Michael Acceptors
- (2010) Dominik Wondrousch et al. Journal of Physical Chemistry Letters
- Quantitative reactivity profiling predicts functional cysteines in proteomes
- (2010) Eranthie Weerapana et al. NATURE
- Therapeutic Protein Kinase Inhibitors
- (2008) S. K. Grant CELLULAR AND MOLECULAR LIFE SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now